Filing Details
- Accession Number:
- 0001209191-21-069415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-14 16:18:00
- Reporting Period:
- 2021-12-13
- Accepted Time:
- 2021-12-14 16:18:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 651311552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1748177 | Bahram Valamehr | C/O Fate Therapeutics, Inc. 12278 Scripps Summit Drive San Diego CA 92131 | Chief R&D Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-13 | 25,000 | $2.73 | 181,698 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-13 | 2,100 | $45.68 | 179,598 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-13 | 7,018 | $46.72 | 172,580 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-13 | 6,564 | $47.61 | 166,016 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-13 | 7,718 | $48.75 | 158,298 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-13 | 1,600 | $49.27 | 156,698 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2021-12-13 | 25,000 | $0.00 | 25,000 | $2.73 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 61,156 | 2027-01-04 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 9, 2020.
- Represents the weighted average sale price of the shares sold from $45.18 to $46.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of he Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6.
- Represents the weighted average sale price of the shares sold from $46.20 to $47.17 per share.
- Represents the weighted average sale price of the shares sold from $47.21 to $48.20 per share.
- Represents the weighted average sale price of the shares sold from $48.21 to $49.20 per share.
- Represents the weighted average sale price of the shares sold from $49.21 to $49.40 per share.
- This option is fully vested.
Billionaire Hedge Funds
